Amino Club Finnrick 2026 Multi-Peptide Industry Report: 43% CAGR Growth, Clinical Efficacy Data & Global Sourcing Guide
Published: July 10, 2026 21:29
Author: Arjun Barrett
Abstract: The 2026 Amino Club Finnrick Multi-Peptide Industry Report reveals a 43% CAGR driven by clinical efficacy data from copper tripeptide-1 and GHK-Cu. Our analysis compares 12 global brands (e.g., Finnrick vs. Matrixyl 3000) on purity (>98%), stability (lyophilized vs. liquid), and certifications (GMP, ISO 22716). Sourcing advantages include cold-chain logistics protocols and batch-specific COAs. The report guides selection based on application (anti-aging, wound healing) and regulatory compliance (FDA NDI, EU Novel Food).